These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
387 related articles for article (PubMed ID: 29803274)
21. Inhibitor antibodies to factor VIII and factor IX: management. Lusher JM Semin Thromb Hemost; 2000; 26(2):179-88. PubMed ID: 10919411 [TBL] [Abstract][Full Text] [Related]
22. Management of joint bleeding in hemophilia. Simpson ML; Valentino LA Expert Rev Hematol; 2012 Aug; 5(4):459-68. PubMed ID: 22992238 [TBL] [Abstract][Full Text] [Related]
23. Switching to extended half-life products in Canada - preliminary data. Keepanasseril A; Stoffman J; Bouskill V; Carcao M; Iorio A; Jackson S; Haemophilia; 2017 Jul; 23(4):e365-e367. PubMed ID: 28548284 [No Abstract] [Full Text] [Related]
24. Hemophilia with factor VIII and factor IX inhibitors, incidence, bleeding problems and management. Mahasandana C; Patharathienskul D; Suvatte V Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():106-12. PubMed ID: 7886549 [TBL] [Abstract][Full Text] [Related]
25. Substitution treatment of hemophilia a and b. Duckert F Schweiz Med Wochenschr; 1975 Jun; 105(24):783-4. PubMed ID: 1145162 [TBL] [Abstract][Full Text] [Related]
26. The use of enhanced half-life coagulation factor concentrates in routine clinical practice: guidance from UKHCDO. Collins P; Chalmers E; Chowdary P; Keeling D; Mathias M; O'Donnell J; Pasi KJ; Rangarajan S; Thomas A Haemophilia; 2016 Jul; 22(4):487-98. PubMed ID: 27311929 [TBL] [Abstract][Full Text] [Related]
27. Efficacy of self-therapy in hemophilia. A study of 72 patients with hemophilia A and B. Levine PH N Engl J Med; 1974 Dec; 291(26):1381-4. PubMed ID: 4427642 [No Abstract] [Full Text] [Related]
28. Cataract surgery in haemophilia. Mauser-Bunschoten EP; Bijlsma W; Roosendaal G; Schutgens RE Haemophilia; 2013 Nov; 19(6):e371-2. PubMed ID: 23773276 [No Abstract] [Full Text] [Related]
33. Eloctate for hemophilia A. Med Lett Drugs Ther; 2015 Oct; 57(1479):143-4. PubMed ID: 26445206 [TBL] [Abstract][Full Text] [Related]
34. [Advances in the field of hemophilia therapy]. Loeliger EA; Veltkamp JJ Ned Tijdschr Geneeskd; 1968 Sep; 112(36):1593-5. PubMed ID: 5680135 [No Abstract] [Full Text] [Related]
35. Intraarticular bleeding in children with hemophilia: the prevention of arthropathy. Gregosiewicz A; Wośko I; Kandzierski G J Pediatr Orthop; 1989; 9(2):182-5. PubMed ID: 2494223 [TBL] [Abstract][Full Text] [Related]
36. Progress in the treatment of bleeding disorders. Bergman GE Thromb Res; 2011 Jan; 127 Suppl 1():S3-5. PubMed ID: 21035836 [TBL] [Abstract][Full Text] [Related]
37. [Diagnosis and treatment of congenital and acquired hemophilia]. Higasa S Rinsho Ketsueki; 2017; 58(7):857-865. PubMed ID: 28781285 [TBL] [Abstract][Full Text] [Related]
38. [Hemophilia and HTLV-III infection]. Lechler E Z Hautkr; 1986 Dec; 61(23):1687-704. PubMed ID: 2949442 [TBL] [Abstract][Full Text] [Related]
39. The current approach to hemophilia. Morrison CJ J Maine Med Assoc; 1974 Sep; 65(9):205-6. PubMed ID: 4416140 [No Abstract] [Full Text] [Related]
40. Supervised patient-management of hemophilia. A study of 45 patients with hemophilia A and B. Levine PH; Britten AF Ann Intern Med; 1973 Feb; 78(2):195-201. PubMed ID: 4630527 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]